SCHEMBL10890235

SCHEMBL10890235

O=C(NC1=NN(c2nc3c(s2)CCCC3)CC1)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.39
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ SLC27A1 Q6PCB7 7/20 0.37
▸ LMNA P02545 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ TP53 P04637 2/20 0.36
▸ HTT P42858 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ GAA P10253 3/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ PTBP1 P26599 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10893914 0.84 ABL1 (0.44) TSHRNPC1RAB9ASLC27A1LMNA
Hydrochloric Acid SCHEMBL10889776 0.82 ABL1 (0.43) TSHRNPC1RAB9ASLC27A1LMNA
SCHEMBL10891333 0.78 TSHR (0.38) TSHRNPC1RAB9ALMNAMAPT
SCHEMBL10888736 0.78 PDK1 (0.33) NPC1RAB9ASLC27A1LMNATP53
SCHEMBL6999293 0.74 TSHR (0.61) TSHRNPC1RAB9ALMNAMAPT
SCHEMBL10890832 0.73 NPC1 (0.37) TSHRNPC1RAB9ASLC27A1LMNA
Hydrochloric Acid SCHEMBL10891755 0.72 NPC1 (0.36) TSHRNPC1RAB9ASLC27A1LMNA
SCHEMBL11054645 0.69 MEN1 (0.61) NPC1RAB9AMAPTTP53ALDH1A1
SCHEMBL10893459 0.68 APOBEC3A (0.49) TSHRNPC1RAB9ALMNAMAPT
SCHEMBL11057384 0.68 GAA (0.50) MAPTALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4600722-A 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a process for the treatment of inflammatory or allergic processes in humans A. NATTERMANN & CIE GMBH (DE) 1986-07-15 — — US disclosed
Send feedback